Clarity - Rapid Test Kit Antigen Detection Covid-19 Antigen Nasopharyngeal Swab Sample 25 Tests - CLA-COV19AG-VIS

This product may require 7-10 business days to process and prepare for shipping. 

• The Sienna-Clarity COVID-19 Antigen Rapid Test Cassette is only for use under the Food and Drug Administration’s Emergency Use Authorization: https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/in-vitro-diagnostics-euas-antigen-diagnostic-tests-sars-cov-2
• This test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation
• Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, that meet the requirements to perform moderate complexity, high complexity, or waived tests
• The Sienna-Clarity COVID-19 Antigen Rapid Test Cassette is a rapid chromatographic immunoassay intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in direct nasopharyngeal swab (NP) specimens from individuals who are suspected of COVID-19 by their healthcare provider within the first six days of symptom onset
• Laboratories within the United States and its territories are required to report all results to the appropriate public health laboratories
• For prescription use only
• Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status
• Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease
• Negative results should be treated as presumptive and confirmation with a molecular assay, if necessary, for patient management, may be performed
• Negative results do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions
• Negative results should be considered in the context of a patient’s recent exposures, history, and the presence of clinical signs and symptoms consistent with COVID-19
• The Sienna-Clarity COVID-19 Antigen Rapid Test Cassette is intended for use by trained clinical laboratory personnel and individuals trained in point of care
• Relative Sensitivity 87.5%
• Relative Specificity: >98.9%
• Fast and Easy - Positive results as fast as 5 minutes

Stock Number : 1197378

Manufacturer # : CLA-COV19AG-VIS

Brand : Clarity

Manufacturer : Clarity Diagnostics LLC

Country of Origin : Finland

Application : Rapid Test Kit

CLIA Classification : CLIA Waived for Point of Care

Contents 1 : (25) Test Cassettes , (25) Sterile Naso-Pharyngeal Swabs , (25) Buffers, Package Insert, QSG, Negative Control Swab, Positive Control Swab

HCPCS : U0003

Number of Tests : 25 Tests

Product Dating : McKesson Acceptable Dating: we will ship >= 90 days

Reading Type : Visual Read

Sample Type : Nasopharyngeal Swab Sample

Test Format : Cassette Format

Test Method : Lateral Flow Immunoassay

Test Name : Covid-19 Antigen

Test Type : Antigen Detection

Time to Results : 5 Minute Results

UNSPSC Code : 41116205

RAPID TEST, COVID-19 NASOPHARYNGEAL SWAB (25/BX 49BX/CS)